Atlas Trials

ASLAN Pharmaceuticals

20 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch ASLAN Pharmaceuticals

RecordFirmDate
Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants (NCT05865041)ASLAN Pharmaceuticals2023-04-14
Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab (NCT05694884)ASLAN Pharmaceuticals2022-12-21
Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis (NCT05158023)ASLAN Pharmaceuticals2022-03-16
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneously Delivered ASLAN004 in Adults With Moderate-Severe Atopic Dermatitis (NCT04090229)ASLAN Pharmaceuticals2019-09-09
Study of ASLAN004 in Healthy Subjects (NCT03721263)ASLAN Pharmaceuticals2018-10-15
Study of Varlitinib Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer (NCT03129074)ASLAN Pharmaceuticals2018-05-01
A Dose Optimisation Study of ASLAN003 in Acute Myeloid Leukemia (NCT03451084)ASLAN Pharmaceuticals2018-01-05
Varlitinib Plus Capecitabine in Chinese Patients With Advanced or Metastatic Biliary Tract Cancer (NCT03231176)ASLAN Pharmaceuticals2017-12-19
Open, Single-dose/-Period Study to Assess Mass Balance Recovery, Metabolite Profile/Identification of 14C-Varlitinib (NCT03368846)ASLAN Pharmaceuticals2017-11-23

Track ASLAN Pharmaceuticals automatically

Every clearance here is in the API, with alerts when new ones post.